NCT04414085

Brief Summary

data from charts regarding clinical characteristics and androgens levels from first to last visit were collected

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2015

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2020

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 22, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
Last Updated

June 4, 2020

Status Verified

May 1, 2020

Enrollment Period

4.6 years

First QC Date

May 22, 2020

Last Update Submit

May 29, 2020

Conditions

Retrospective

Outcome Measures

Primary Outcomes (1)

  • Presence of hyperandrogenism signs (1 to 3 categorized)

    hirsuitism, acne, menses, each marked as 0 or 1 (none or present)

    3 years

Eligibility Criteria

Age10 Years - 18 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All referred to gynecology endocrinology adolescents clinic who underwent an ACTH stimulation test

You may qualify if:

  • age 10-18 years referred to gynecology endocrinology adolescents clinic

You may not qualify if:

  • no data available in chart no blood work available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Harofeh Medical Center

Ẕerifin, 70300, Israel

Location

Study Officials

  • galia barash, md

    Assaf-Harofeh Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Galia Askapa

Study Record Dates

First Submitted

May 22, 2020

First Posted

June 4, 2020

Study Start

October 15, 2015

Primary Completion

May 15, 2020

Study Completion

May 15, 2020

Last Updated

June 4, 2020

Record last verified: 2020-05

Locations

IL(1)